FDA Announces Recall of Cubicin (daptomycin for injection): AttorneyOne Monitor and Keep Consumers Informed

As the FDA announced on April 18, one lot of Cubicin (daptomycin for injection), by Cubist Pharmaceuticals, is recalled due to the presence of particular matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Cubicin Recall

Cubicin Recall

Increased risk applies in the cases of patients with preexisting condition of trauma or other medical condition.

San Diego, CA (PRWEB) April 25, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for drugs.

On April 18, the US FDA announced that one lot of Cubicin (daptomycin for injection) 500 mg Lot No. 280453F, by Cubist Pharmaceuticals, is recalled due to the presence of particulate matter, identified as glass particles. This may pose a safety risk to patients including: thromboembolism, pulmonary emboli, phlebitis, mechanical block of the capillaries or arterioles, activation of platelets, subsequent generation of microthrombi, and emboli.

Moreover, increased risk applies in the cases of patients with preexisting condition of trauma or other medical condition that adversely affects the microvascular blood supply.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning drugs and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA recommends “Anyone with an existing inventory of the product lot listed should determine whether they have product from the recalled lot, quarantine and discontinue distribution of this recalled lot of the product. The announcement continues mentioning that patients should call Cubist to arrange for return and replacement of the affected lot.

AttorneyOne.com has further information on prescription products at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/04/prweb11791514.htm.